Danaher Corporation $DHR Shares Sold by AlTi Global Inc.

Key Points

• AlTi Global Inc. reduced its stake in Danaher Corporation by 23% in Q1, now holding 8,793 shares worth approximately $1.8 million.
• Analysts have cut price targets for Danaher, with Deutsche Bank lowering it to $235 and UBS to $225, but many maintain a "buy" rating.
• Danaher reported earnings of $1.80 per share, exceeding expectations, alongside quarterly revenue of $5.94 billion, an increase of 3.4% year-over-year.

AlTi Global Inc. lessened its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 23.0% in the first quarter, according to its most recent filing with the SEC. The firm owned 8,793 shares of the conglomerate's stock after selling 2,627 shares during the quarter. AlTi Global Inc.'s holdings in Danaher were worth $1,805,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. GHP Investment Advisors Inc. boosted its position in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $27,000. Sierra Ocean LLC lifted its holdings in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Danaher in the first quarter valued at $31,000. Finally, Dunhill Financial LLC lifted its holdings in shares of Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after buying an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on DHR shares. Deutsche Bank Aktiengesellschaft cut their price objective on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. UBS Group cut their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price objective on Danaher in a report on Tuesday. Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Finally, Evercore ISI cut their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $246.35.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 11.20% of the company's stock.

Danaher Stock Down 2.2%

Shares of Danaher stock opened at $199.40 on Thursday. The stock's fifty day moving average is $201.94 and its 200-day moving average is $199.49. The firm has a market capitalization of $142.78 billion, a PE ratio of 42.43, a price-to-earnings-growth ratio of 2.87 and a beta of 0.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.